Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canary Global is a health technology company specializing in rapid, digital diagnostic solutions for infectious diseases and oncology. The company's flagship platform, Canary Detect, utilizes advanced electrochemical sensor technology to provide highly accurate results for various diseases within minutes. Their initial commercial focus was on ultra-rapid COVID-19 testing using saliva samples, but the platform is being expanded to detect various cancers, including oral cancer, through non-invasive sampling. By combining biotechnology with digital connectivity and cloud-based analytics, Canary Global aims to decentralize testing and improve patient outcomes through early intervention and real-time monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canary Global.